Cannabis Suisse Corp. Logo

Cannabis Suisse Corp.

CSUI

(1.8)
Stock Price

0,01 USD

-154.49% ROA

165.6% ROE

-1.05x PER

Market Cap.

1.979.065,00 USD

-149.01% DER

0% Yield

-5783.19% NPM

Cannabis Suisse Corp. Stock Analysis

Cannabis Suisse Corp. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cannabis Suisse Corp. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (107.87%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-2.83x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-165%), which means it has a small amount of debt compared to the ownership it holds

4 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

5 ROA

The stock's ROA (-102.24%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Cannabis Suisse Corp. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cannabis Suisse Corp. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Cannabis Suisse Corp. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cannabis Suisse Corp. Revenue
Year Revenue Growth
2016 0
2017 14.192 100%
2018 6.500 -118.34%
2019 7.530 13.68%
2020 242.739 96.9%
2021 50.850 -377.36%
2022 7.770 -554.44%
2023 10.000 22.3%
2024 30.000 66.67%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cannabis Suisse Corp. Research and Development Expenses
Year Research and Development Expenses Growth
2016 0
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cannabis Suisse Corp. General and Administrative Expenses
Year General and Administrative Expenses Growth
2016 1.600
2017 22.408 92.86%
2018 13.723 -63.29%
2019 22.217 38.23%
2020 246.458 90.99%
2021 297.006 17.02%
2022 161.192 -84.26%
2023 339.272 52.49%
2024 319.016 -6.35%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cannabis Suisse Corp. EBITDA
Year EBITDA Growth
2016 0
2017 -24.084 100%
2018 -9.526 -152.82%
2019 -17.225 44.7%
2020 -331.245 94.8%
2021 -336.031 1.42%
2022 -155.156 -116.58%
2023 -338.438 54.16%
2024 -4.250.344 92.04%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cannabis Suisse Corp. Gross Profit
Year Gross Profit Growth
2016 0
2017 10.294 100%
2018 4.197 -145.27%
2019 4.992 15.93%
2020 -84.787 105.89%
2021 -51.798 -63.69%
2022 6.036 958.15%
2023 834 -623.74%
2024 -7.768 110.74%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cannabis Suisse Corp. Net Profit
Year Net Profit Growth
2016 -1.732
2017 -26.672 93.51%
2018 -16.421 -62.43%
2019 -22.728 27.75%
2020 -389.228 94.16%
2021 -471.238 17.4%
2022 -218.625 -115.55%
2023 -351.547 37.81%
2024 -4.308.404 91.84%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cannabis Suisse Corp. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2016 0
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cannabis Suisse Corp. Free Cashflow
Year Free Cashflow Growth
2016 -16.140
2017 -55.073 70.69%
2018 -6.400 -760.52%
2019 -11.860 46.04%
2020 -288.828 95.89%
2021 -130.606 -121.14%
2022 -32.089 -307.01%
2023 -163.960 80.43%
2024 -406 -40284.24%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cannabis Suisse Corp. Operating Cashflow
Year Operating Cashflow Growth
2016 -8.328
2017 -32.221 74.15%
2018 -6.400 -403.45%
2019 -11.860 46.04%
2020 -288.828 95.89%
2021 -130.606 -121.14%
2022 -32.089 -307.01%
2023 -163.960 80.43%
2024 -406 -40284.24%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cannabis Suisse Corp. Capital Expenditure
Year Capital Expenditure Growth
2016 7.812
2017 22.852 65.81%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cannabis Suisse Corp. Equity
Year Equity Growth
2016 1.567
2017 9.090 82.76%
2018 -7.331 223.99%
2019 19.941 136.76%
2020 -386.508 105.16%
2021 -187.494 -106.14%
2022 -274.092 31.59%
2023 -329.447 16.8%
2024 -1.423.846 76.86%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cannabis Suisse Corp. Assets
Year Assets Growth
2016 4.947
2017 38.190 87.05%
2018 28.169 -35.57%
2019 332.586 91.53%
2020 383.525 13.28%
2021 6.567 -5740.19%
2022 0 0%
2023 346.303 100%
2024 818.607 57.7%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cannabis Suisse Corp. Liabilities
Year Liabilities Growth
2016 3.380
2017 29.100 88.38%
2018 35.500 18.03%
2019 312.645 88.65%
2020 770.033 59.4%
2021 194.061 -296.8%
2022 274.092 29.2%
2023 675.750 59.44%
2024 2.242.453 69.87%

Cannabis Suisse Corp. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.03
Price to Earning Ratio
-1.05x
Price To Sales Ratio
65.97x
POCF Ratio
-29.06
PFCF Ratio
-43.41
Price to Book Ratio
-0.93
EV to Sales
142.23
EV Over EBITDA
-3.46
EV to Operating CashFlow
-93.59
EV to FreeCashFlow
-93.59
Earnings Yield
-0.95
FreeCashFlow Yield
-0.02
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.13
Graham NetNet
-0.05

Income Statement Metrics

Net Income per Share
-0.03
Income Quality
0.04
ROE
1.88
Return On Assets
-2.08
Return On Capital Employed
-0.45
Net Income per EBT
1
EBT Per Ebit
6.4
Ebit per Revenue
-9.04
Effective Tax Rate
0.57

Margins

Sales, General, & Administrative to Revenue
8.42
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.05
Operating Profit Margin
-9.04
Pretax Profit Margin
-57.83
Net Profit Margin
-57.83

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0.08
Return on Tangible Assets
-1.54
Days Sales Outstanding
0
Days Payables Outstanding
50.47
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
7.23
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,03
Tangible Book Value per Share
-0.03
Shareholders Equity per Share
-0.03
Interest Debt per Share
0.05
Debt to Equity
-1.49
Debt to Assets
2.59
Net Debt to EBITDA
-1.85
Current Ratio
0.44
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
437607
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
1.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cannabis Suisse Corp. Dividends
Year Dividends Growth

Cannabis Suisse Corp. Profile

About Cannabis Suisse Corp.

Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. The company sells its products through Swiss4Life, a retail brand for online selling, as well as a network of retailers. It provides health-related supplements, and face masks and disinfectants, as well as retails cigarettes. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. was incorporated in 2016 and is based in Bell Gardens, California.

CEO
Mr. Scott W. Mcalister
Employee
0
Address
6607 Clara St #270
Bell Gardens, 90201

Cannabis Suisse Corp. Executives & BODs

Cannabis Suisse Corp. Executives & BODs
# Name Age
1 Mr. Scott W. Mcalister
Chief Executive Officer, Chief Financial Officer & Director
70

Cannabis Suisse Corp. Competitors